Skip to main content
TipRanks
Go Ultimate75% OFF

Chong Kun Dang Pharmaceutical Corp. (185750) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Chong Kun Dang Pharmaceutical Corp. has a market cap or net worth of KRW 809.01B. The enterprise value is KRW 983.31B.

Market Cap
KRW 809.01B
Enterprise Value
KRW 983.31B

Share Statistics

Chong Kun Dang Pharmaceutical Corp. has 13,802,780 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
13,802,780
Owned by Insiders
―
Owned by Institutions
9.11%

Financial Efficiency

Chong Kun Dang Pharmaceutical Corp.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.30%.

Return on Equity (ROE)
0.08
Return on Assets (ROA)
0.04
Return on Invested Capital (ROIC)
5.30%
Return on Capital Employed (ROCE)
0.06
Revenue Per Employee
734.55M
Profits Per Employee
33.78M
Employee Count
2,304
Asset Turnover
0.94
Inventory Turnover
2.74

Valuation Ratios

The current PE Ratio of Chong Kun Dang Pharmaceutical Corp. is 10.18. Chong Kun Dang Pharmaceutical Corp.’s PEG ratio is 0.33.

PE Ratio
10.18
PS Ratio
0.45
PB Ratio
0.83
Price to FCF
-11.69
Price to Operating Cash Flow
6.88
PEG Ratio
0.33

Income Statement

In the last 12 months, Chong Kun Dang Pharmaceutical Corp. had revenue of 1.69T and earned 77.83B in profits. Earnings per share was 5882.09.

Revenue
1.69T
Gross Profit
517.23B
Operating Income
80.57B
Pretax Income
81.65B
Net Income
77.83B
EBITDA
125.37B
Earnings Per Share (EPS)
5882.09

Cash Flow

In the last 12 months, operating cash flow was 123.26B and capital expenditures -192.48B, giving a free cash flow of -69.22B billion.

Operating Cash Flow
123.26B
Free Cash Flow
-69.22B
Free Cash Flow per Share
-5014.80

Dividends & Yields

Chong Kun Dang Pharmaceutical Corp. pays an annual dividend of ―, resulting in a dividend yield of 0.81%

Dividend Per Share
―
Dividend Yield
0.81%
Payout Ratio
N/A
Free Cash Flow Yield
-8.56%
Earnings Yield
9.38%

Stock Price Statistics

Beta
0.10
52-Week Price Change
-29.18%
50-Day Moving Average
64712.00
200-Day Moving Average
75283.00
Relative Strength Index (RSI)
43.61
Average Volume (3m)
19.22K

Important Dates

Chong Kun Dang Pharmaceutical Corp. upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Mar 24, 2027
Ex-Dividend Date
―

Financial Position

Chong Kun Dang Pharmaceutical Corp. as a current ratio of 2.12, with Debt / Equity ratio of 36.64%

Current Ratio
2.12
Quick Ratio
1.28
Debt to Market Cap
0.33
Net Debt to EBITDA
1.21
Interest Coverage Ratio
12.03

Taxes

In the past 12 months, Chong Kun Dang Pharmaceutical Corp. has paid 3.83B in taxes.

Income Tax
3.83B
Effective Tax Rate
0.05

Enterprise Valuation

Chong Kun Dang Pharmaceutical Corp. EV to EBITDA ratio is 8.50, with an EV/FCF ratio of -15.23.

EV to Sales
0.59
EV to EBITDA
8.50
EV to Free Cash Flow
-15.23
EV to Operating Cash Flow
8.55

Balance Sheet

Chong Kun Dang Pharmaceutical Corp. has KRW 329.30B in cash and marketable securities with KRW 437.44B in debt, giving a net cash position of -KRW 108.14B billion.

Cash & Marketable Securities
KRW 329.30B
Total Debt
KRW 437.44B
Net Cash
-KRW 108.14B
Net Cash Per Share
-KRW 7,834.92
Tangible Book Value Per Share
KRW 63.90K

Margins

Gross margin is 29.03%, with operating margin of 4.33%, and net profit margin of 4.46%.

Gross Margin
29.03%
Operating Margin
4.33%
Pretax Margin
4.31%
Net Profit Margin
4.46%
EBITDA Margin
6.95%
EBIT Margin
4.39%

Analyst Forecast

The average price target for Chong Kun Dang Pharmaceutical Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
7.15%
EPS Growth Forecast
29.88%

Scores

Smart Score
―
AI Score
57